¼¼°èÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå - »ê¾÷±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ¾à¹° À¯Çüº°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Application, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1692279
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå ±Ô¸ð´Â 2024³â 13¾ï 3,000¸¸ ´Þ·¯¿´°í, 2030³â±îÁö ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR) 9.42%·Î ¿¹ÃøµÇ¾î ±â°£ Áß¿¡ Å« ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº Á¦¾à ¹× »ý¸í°øÇÐ ºÐ¾ß¿¡¼­ ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå´Â ÀϹÝÀûÀ¸·Î Á¤Á¦, ĸ½¶ ¹× ¾×üÀÇ ÇüÅ·Π°æ±¸ ¼·ÃëÇÒ ¼ö ÀÖ´Â »ý¹°ÇÐÀû Ȱ¼º ºÐÀÚÀ̸ç, ÁÖ»ç ¿ä¹ýÀ» ´ëüÇÏ´Â Ä¡·á¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Åõ¿© ¹æ¹ýÀº ȯÀÚÀÇ ÄÄÇöóÀ̾𽺠Çâ»ó, ºÒÆíÇÔ °¨¼Ò, °Ç°­ °ü¸® ºñ¿ë Àý°¨ µî ¿©·¯ °¡Áö ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 13¾ï 3,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 22¾ï 6,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 9.42%
±Þ¼ºÀå ºÎ¹® ÇÁ¸®Ä«³ªÆ¼µå
ÃÖ´ë ½ÃÀå ºÏ¹Ì

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¸¸¼º Áúȯ Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

¾ÈÁ¤¼º ¹× »ýüÀÌ¿ë·ü

ÁÖ¿ä ½ÃÀå µ¿Çâ :

³ª³ë±â¼ú ¹× ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ ¹ßÀü

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æ±¸ ´Ü¹éÁú ¹× ÆéƼµå ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Oral Proteins & Peptides Market was valued at USD 1.33 billion in 2024 and is expected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 9.42% through 2030. This market is rapidly expanding within the pharmaceutical and biotechnology sectors. Oral proteins and peptides are bioactive molecules that can be taken orally, typically in the form of tablets, capsules, or liquids, providing an alternative to injectable therapies. This method of administration offers multiple advantages, including improved patient compliance, reduced discomfort, and lower healthcare costs.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.33 Billion
Market Size 2030USD 2.26 Billion
CAGR 2025-20309.42%
Fastest Growing SegmentPlecanatide
Largest MarketNorth America

Key Market Drivers:

Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a key factor driving the growth of the oral proteins and peptides market. As the global population ages and lifestyles become more sedentary and unhealthy, the incidence of chronic diseases is increasing. This leads to a larger patient pool that could benefit from oral protein and peptide treatments. According to the World Health Organization, noncommunicable diseases (NCDs) were responsible for 43 million deaths, accounting for 75% of all global deaths unrelated to pandemics. Cardiovascular diseases were the leading cause with 19 million deaths, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million). Notably, low- and middle-income countries accounted for 73% of these NCD-related deaths.

Patients with chronic conditions are increasingly seeking convenient treatment options. Many require long-term or lifelong therapies, and traditional methods such as injections or infusions can be burdensome. Oral proteins and peptides provide a more patient-friendly alternative, as they can be taken in the form of a pill or liquid, eliminating the need for painful, frequent injections. Additionally, non-adherence to prescribed treatments is a significant challenge in managing chronic diseases. Oral formulations help address this issue by increasing patient compliance, as treatments that are easier to administer and less intrusive encourage better adherence and lead to improved health outcomes.

Key Market Challenges:

Stability and Bioavailability

A major challenge in the oral administration of proteins and peptides is their susceptibility to degradation in the harsh environment of the gastrointestinal tract. Ensuring their stability and maintaining adequate bioavailability remains a complex issue that requires advanced formulation technologies.

Key Market Trends:

Advancements in Nanotechnology and Drug Delivery Systems

Nanotechnology is transforming drug delivery in the oral proteins and peptides market. Nanoparticles and nanocarriers are being developed to encapsulate and protect these sensitive molecules, enabling more precise delivery and enhanced bioavailability. These innovations are expected to expand the range of treatable diseases and improve therapeutic outcomes.

Key Market Players:

Report Scope:

This report segments the Global Oral Proteins & Peptides Market into the following categories, with detailed insights into each:

By Drug Type:

By Application:

By Region:

Competitive Landscape and Company Profiles:

This section offers an in-depth analysis of the major players in the Global Oral Proteins & Peptides Market.

Available Customizations:

TechSci Research provides customized reports tailored to specific market needs. The following customization options are available:

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Oral Proteins & Peptides Market Outlook

6. North America Oral Proteins & Peptides Market Outlook

7. Europe Oral Proteins & Peptides Market Outlook

8. Asia-Pacific Oral Proteins & Peptides Market Outlook

9. South America Oral Proteins & Peptides Market Outlook

10. Middle East and Africa Oral Proteins & Peptides Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â